Helicobacter Pylori Diagnostics Market - Global Forecast, 2022 - 2028

Helicobacter Pylori Diagnostics Market - Global Forecast, 2022 - 2028

Report Description
Helicobacter pylori is a bacteria that resides on the lining of human stomach. Helicobacter produces chemicals, causing inflammation of stomach, which progresses to peptic ulcer or gastric cancer. Helicobacter pylori infection can be detected by simple and accurate tests such as breath test, blood tests, endoscopy, and stool tests. Based on the sample preparation, helicobacter pylori diagnostic assays are segmented into invasive methods, which includes immunoassay, rapid urease test, and histology, and Non-invasive methods, which includes stool antigen assay, serology test and urease breath test. Increasing infection prevalence in emerging economies and high demand for point-of-care testing are major factors driving growth of Helicobacter pylori diagnostics market.
Market Dynamics
Market players are investing in developing point-of-care and accurate diagnostics products to gain competitive advantage. For instance, in 2021, Exaleza Bioscience launched Automated BreathID Hp Lab Urea Breath Testing System for detection of Helicobacter pylori. The system is point-of-care, with 99% sensitivity and specificity for H. pylori. Furthermore, companies are focusing enhancing product portfolio through inorganic growth strategies. For instance, Abbott Laboratories acquired Alere Inc., the global leader in point of care diagnostics, in order to expand its product portfolio and geographic presence. With this acquisition, Abbott could access to Alere’s rapid diagnostics segment, which includes H. pylori detection kits. However, limitations associated with the currently available diagnostic assays are expected to restrain the Helicobacter pylori diagnostics market. For instance, urea breath test and stool antigen test cannot be used in patients undergoing proton pump inhibitors treatment.
Key features of the study:
This report provides in-depth analysis of the Helicobacter pylori diagnostics market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, product recalls, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global helicobacter pylori diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics.
The global Helicobacter pylori diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of helicobacter pylori diagnostic tests/devices, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the Helicobacter pylori diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
Global Helicobacter Pylori Diagnostics Market, By Test Type:
Invasive
Immunoassay
Rapid Urease Test
Histology
Non-invasive
Stool Antigen Assays
Serology Tests
Urea Breath Test
Global Helicobacter Pylori Diagnostics Market, By End User:
Hospitals
Clinics
Diagnostic Laboratories
Others
Global Helicobacter Pylori Diagnostics Market, By Region:
North America Helicobacter Pylori Diagnostics Market
By Test Type:
Invasive
Immunoassay
Rapid Urease Test
Histology
Non-invasive
Stool Antigen Assays
Serology Tests
Urea Breath Test
By End User:
Hospitals
Clinics
Diagnostic Laboratories
Others
By Country:
U.S.
Canada
Latin America Helicobacter Pylori Diagnostics Market
By Test Type:
Invasive
Immunoassay
Rapid Urease Test
Histology
Non-invasive
Stool Antigen Assays
Serology Tests
Urea Breath Test
By End User:
Hospitals
Clinics
Diagnostic Laboratories
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe Helicobacter Pylori Diagnostics Market
By Test Type:
Invasive
Immunoassay
Rapid Urease Test
Histology
Non-invasive
Stool Antigen Assays
Serology Tests
Urea Breath Test
By End User:
Hospitals
Clinics
Diagnostic Laboratories
Others
By Country:
Germany
U.K.
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific Helicobacter Pylori Diagnostics Market
By Test Type:
Invasive
Immunoassay
Rapid Urease Test
Histology
Non-invasive
Stool Antigen Assays
Serology Tests
Urea Breath Test
By End User:
Hospitals
Clinics
Diagnostic Laboratories
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East Helicobacter Pylori Diagnostics Market
By Test Type:
Invasive
Immunoassay
Rapid Urease Test
Histology
Non-invasive
Stool Antigen Assays
Serology Tests
Urea Breath Test
By End User:
Hospitals
Clinics
Diagnostic Laboratories
Others
By Country:
GCC
Israel
Rest of Middle East
Africa Helicobacter Pylori Diagnostics Market
By Test Type:
Invasive
Immunoassay
Rapid Urease Test
Histology
Non-invasive
Stool Antigen Assays
Serology Tests
Urea Breath Test
By End User:
Hospitals
Clinics
Diagnostic Laboratories
Others
By country:
North Africa
Central Africa
South Africa
Company Profiles
Thermo Fisher Scientific, Inc.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Bio-Rad Laboratories Inc.
Diasorin S.P.A.
Quidel Corporation
F. Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.)
Meridian Bioscience, Inc.
Exalenz Bioscience Ltd.
Abbott Laboratories
Cardinal Health, Inc.
Halyard Health, Inc.
Strategies “*” marked represents similar segmentation in other categories in the respective section.